ClinicalTrials.Veeva
Menu

Find clinical trials for Eczema in Cleveland, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Atopic Dermatitis
Dermatitis
Skin Diseases
Immune System Diseases
Eczematous Skin Diseases
Pruritus
Food Hypersensitivity

Eczema trials near Cleveland, OH, USA:

Locations recently updated

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

effective for the treatment of atopic dermatitis (AD), also known as eczema, or atopic eczema. People with this condition may have ...

Enrolling
Eczema, Atopic
Atopic Dermatitis
Drug: PF-08049820
Drug: Placebo

Phase 2

Pfizer
Pfizer

Mayfield Heights, Ohio, United States and 32 other locations

The purpose of this study is to evaluate the safety and efficacy of long-term treatment with IMG-007 in participants with moderate-to-severe atopic d...

Invitation-only
Atopic Dermatitis Eczema
Eczema
Drug: IMG-007

Phase 2

Inmagene

Mayfield Heights, Ohio, United States and 22 other locations

The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.

Enrolling
Atopic Dermatitis Eczema
Eczema
Drug: Placebo
Drug: IMG-007

Phase 2

Inmagene

Mayfield Heights, Ohio, United States and 39 other locations

This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...

Active, not recruiting
Atopic Dermatitis
Drug: Placebo
Drug: ADX-914

Phase 2

Q32 Bio

Painesville, Ohio, United States and 27 other locations

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...

Active, not recruiting
Atopic Dermatitis (AD)
Biological: BFB759
Drug: Placebo

Phase 2

Bluefin Biomedicine, Inc.

Mayfield Heights, Ohio, United States and 88 other locations

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...

Enrolling
Atopic Dermatitis
Drug: PF-07275315
Other: Placebo

Phase 2

Pfizer
Pfizer

Mayfield Heights, Ohio, United States and 102 other locations

This is an interventional, randomized, parallel group, treatment, Phase IIb, double blind, 4-arm study to assess the effect of pegylated-recombinant-...

Active, not recruiting
Moderate to Severe Atopic Dermatitis
Drug: Rezpegaldesleukin
Drug: Placebo

Phase 2

Nektar Therapeutics
Nektar Therapeutics

Mayfield Heights, Ohio, United States and 118 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems